Pt | Duration of treatment (months) | Findings at the end of treatment | Duration of follow-up after treatment discontinuation (months) | |||||||
---|---|---|---|---|---|---|---|---|---|---|
ESR mm/hr | CRP mg/L | SAT titers | WBC K/μl | Clinical | MRI residual findings | F-18 FDG PET/CT findings | F-18 FDG PET/CT SUVmax | |||
1 | 12 | 40 | 5.00 | 1/320 | 4.70 | (−) | L5 – S1 | L2 – L3, L5 – S1 | 3.2 2.6 | 27 |
2 | 12 | 10 | 5.00 | 1/680 | 6.50 | (−) | T7 – T8 | T7 – T8, L4 – L5 | 3.3 2.0 | 13 |
3 | 9 | 5 | 3.08 | 1/ 10240 | 4.43 | (−) | L2 – L3 | L3 | 2.9 | 21 |
4 | 12 | 35 | 10.00 | 1/320 | 6.65 | (−) | L4 – L5 | L5 T6 | 2.6 2.9 | 10 |
5 | 6 | 15 | 2.97 | < 1/160 | 7.24 | (−) | (−) | (−) | 0 | 9 |
6 | 11 | 15 | 2.97 | 1/320 | 5.15 | Back pain on effort | L4 – L5 | L4 – L5 | 2.7 | 8 |
7 | 12 | 17 | 3.08 | < 1/160 | 7.85 | Pain on weather changes | (−) | T7 | 2.0 | 17 |
8 | 12 | 20 | 4.10 | < 1/160 | 8.90 | (−) | (−) | L3 | 2.0 | 11 |
9 | 6 | 14 | 5.00 | < 1/160 | 7.70 | (−) | (−) | L3 | 3.0 | 21 |
10 | 12 | 23 | 5.00 | < 1/160 | 4.80 | Back pain on effort | L4 – L5 | L1 – L2, L4 – L5 | 2.9 4.4 | 12 |